private:delphinusmedicaltechnologies
|
1869445
|
May 24th, 2019 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.8K
|
51.00
|
Open
|
Biotechnology
|
May 23rd, 2019 09:22PM
|
May 23rd, 2019 09:22PM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
Open
|
Medical Ultrasound
|
Open
|
45525 Grand River Ave.
|
Novi
|
MI
|
US
|
48374
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 16th, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 16th, 2017 02:21PM
|
Dec 16th, 2017 02:21PM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 17th, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 17th, 2017 08:12AM
|
Dec 17th, 2017 08:12AM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 18th, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 18th, 2017 10:19AM
|
Dec 18th, 2017 10:19AM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 19th, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 19th, 2017 05:03AM
|
Dec 19th, 2017 05:03AM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 21st, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 21st, 2017 12:42PM
|
Dec 21st, 2017 12:42PM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 22nd, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 22nd, 2017 05:53AM
|
Dec 22nd, 2017 05:53AM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 23rd, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 23rd, 2017 09:37AM
|
Dec 23rd, 2017 09:37AM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 24th, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 24th, 2017 01:22PM
|
Dec 24th, 2017 01:22PM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|
private:delphinusmedicaltechnologies
|
1869445
|
Dec 25th, 2017 12:00AM
|
Delphinus Medical Technologies, Inc.
|
3.0K
|
56.00
|
Open
|
Biotechnology
|
Dec 25th, 2017 10:21AM
|
Dec 25th, 2017 10:21AM
|
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals.
Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
|
|
|
|
|
|
|
|
|
Health Care
|
Health Care Equipment & Services
|